SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
SEC Accession No. 0001104659-21-149227
Filing Date
2021-12-13
Accepted
2021-12-13 19:04:51
Documents
1
Period of Report
2021-08-23

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm2135158-9_4seq1.html 4/A  
1 OWNERSHIP DOCUMENT tm2135158-9_4seq1.xml 4/A 3182
  Complete submission text file 0001104659-21-149227.txt   4763
Mailing Address 600 MADISON AVENUE, SUITE 1601 NEW YORK NY 10022-1737
Business Address 600 MADISON AVENUE, SUITE 1601 NEW YORK NY 10022-1737 302 355-0650
iBio, Inc. (Issuer) CIK: 0001420720 (see all company filings)

IRS No.: 262797813 | State of Incorp.: DE | Fiscal Year End: 0630
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O IBIO INC. 600 MADISON AVENUE SUITE 1601 NEW YORK NY 10022
Business Address
Isett Thomas Francis 3rd (Reporting) CIK: 0001773100 (see all company filings)

Type: 4/A | Act: 34 | File No.: 001-35023 | Film No.: 211489280